A new concept to stimulate mucosal as well as systemic immunity by parenteral vaccination as applied to the development of a live attenuated Salmonella enterica serovar Dublin vaccine

Veterinary Research

Volumn 38, Issue 6, 2007, Pages 773-794

  Mizuno, Tetsuo ^a   Ploeg, Richard ^a   Trott, Darren ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Bile; Live attenuated vaccine; Mucosal immunity; Parenteral vaccination; Salmonella Dublin

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS); MUS; SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR DUBLIN;

ANTIINFECTIVE AGENT; BILE ACID; LIVE VACCINE; SALMONELLOSIS VACCINE;

ANIMAL; ANIMAL SALMONELLOSIS; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD; CLASSIFICATION; DRUG EFFECT; FECES; FEMALE; GALLBLADDER; GENETICS; HEART; IMMUNOLOGY; LIVER; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOUSE; MUCOSAL IMMUNITY; MUTATION; SALMONELLA ENTERICA; SPLEEN;

ANIMALS; ANTI-BACTERIAL AGENTS; BILE ACIDS AND SALTS; DRUG RESISTANCE, BACTERIAL; FECES; FEMALE; GALLBLADDER; HEART; IMMUNITY, MUCOSAL; LIVER; MICE; MICROBIAL SENSITIVITY TESTS; MUTATION; SALMONELLA ENTERICA; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA VACCINES; SPLEEN; VACCINES, ATTENUATED;

EID: 41449117798     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1051/vetres:2007031     Document Type: Article

References (42)

1. Anderson M., Blanchard P., The clinical syndromes caused by Salmonella infection, Vet. Med. (1989) 84:816-819.
2. Bowersock T.L., Shalaby W.S.W., Levy M., Blevins W.E., White M.R., Borie D.L., Park K., The potential use of poly (methacrylic acid) hydrogels for oral administration of drugs and vaccines to ruminants, J. Control. Release (1994) 31:245-254. (Pubitemid 24301365)
3. Bowersock T.L., HogenEsch H., Suckow M., Guimond P., Martin S., Borie D., Torregrosa S., Park H., Park K., Oral vaccination of animals with antigens encapsulated in algi-nate microspheres, Vaccine (1999) 17:1804-1811. (Pubitemid 29138921)
4. Boyce J.D., Wilkie I., Harper M., Paustian M.L., Kapur V., Adler B., Genomic scale analysis of Pasteurella multocida gene expression during growth within the natural chicken host, Infect. Immun. (2002) 70:6871-6879. (Pubitemid 35387920)
5. Bridson E.Y., The Oxoid Manual, Oxoid, Hampshire, 1998, pp. 3:16-17.
6. Carlton B.C., Brown B.J., Gene Mutation, in: Gerhardt P., Murray R.G., Costilow R.N., Nester E.W., Wood M.W., Krieg N.R., Phillips G.B. (Eds.), Manual of Methods for General Bacteriology, American Society for Microbiology, Washington, DC, 1981, pp. 232-234.
7. Chambers P.G., Lysons R.J., The inhibitory effect of bovine rumen fluid on Salmonella typhimurium, Res. Vet. Sci. (1979) 26:273-276. (Pubitemid 9166326)
8. Cox E., Verdonck F., Vanrompay D., Goddeeris B., Adjuvants modulating mu-cosal immune responses or directing systemic responses towards the mucosa, Vet. Res. (2006) 37:511-539. (Pubitemid 43725034)
9. DesBordes C.K., Welch J.G., Influence of specific gravity on rumination and passage of indigestible particles, J. Anim. Sci. (1984) 59:470-475.
10. Ferraro M.J., Craig W.A., Eliopoulos G., Fung-Tomc J., Hansen S.L., Hecht D.W., Hindler J., Reller L.B., Sahm D.F., Swenson J.M., Tenover F.C., Testa R.T., Wilker M.A., Performance standards for antimicrobial susceptibility testing; Eighth Informational Supplement, NCCLS (1998) 18:1-35.
11. Gerdts V., Mutwiri G.K., Tikoo S.K., Babiuk L.A., Mucosal delivery of vaccines in domestic animals, Vet. Res. (2006) 37:487-510. (Pubitemid 43725033)
12. Griggs D.J., Gensberg K., Piddock L.J.V., Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals, Antimicrob. Agents Chemother. (1996) 40:1009-1013. (Pubitemid 26115239)
13. Guyton A.C., Hall J.E., Textbook of medical physiology, Elsevier Saunders, Pennsylvania, 2006, pp. 802-807.
14. Hinton M., Salmonella dublin abortion in cattle: studies on the clinical aspects of the condition, Br. Vet. J. (1974) 130:556-562.
15. Jin D.J., Gross C.A., Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance, J. Mol. Biol. (1988) 202:45-58.
16. Kaye D., Palmieri M., Rocha H., Effect of bile on the action of blood against Salmonella, J. Bacteriol. (1966) 91:945-952.
17. Kodama C., Eguchi M., Sekiya Y., Yamamoto T., Kikuchi Y., Matsui H., Evaluation of the Lon-deficient Salmonella strain as an oral vaccine candidate, Microbiol. Immunol. (2005) 49:1035-1045. (Pubitemid 41815923)
18. Levine M.M., Dougan G., Optimism over vaccines administered through mucosal surfaces, Lancet (1998) 351:1375-1376. (Pubitemid 28209992)
19. Linde K., Beer J., Bondarenko V., Stable Salmonella live vaccine strains with two or more attenuating mutations and any desired level of attenuation, Vaccine (1990) 8:278-282. (Pubitemid 20198862)
20. Mastroeni P., Cahill B., Simmons C., Dougan G., Vaccines against gut pathogens, Gut (1999) 45:633-635. (Pubitemid 29492127)
21. Matsui H., Suzuki M., Isshiki Y., Kodama C., Eguchi M., Kikuchi Y., Motokawa K., Takaya A., Tomoyasu Y., Yamamoto T., Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar Typhimurium, Infect. Immun. (2003) 71:30-39. (Pubitemid 36026001)
22. McClelland M., Sanderson K.E., Spieth J., Clifton S.W., Latreille P., Courtney L., Porwollik S., Ali J., Dante M., Du F., Hou S., Layman D., Leonard S., Nguyen C., Scott K., Holmes A., Grewal N., Mulvaney E., Ryan E., Sun H., Florea L., Miller W., Stoneking T., Nhan M., Waterston R., Wilson R.K., Complete genome sequence of Salmonella enterica serovar Typhimurium LT2, Nature (2001) 413:852-856. (Pubitemid 33026853)
23. Miles A.A., Misra S.S., Irwin J.O., The estimation of the bactericidal power of the blood, J. Hyg. Camb. (1938) 38:732-749.
24. Oram M., Fisher M., 4-quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction, Antimicrob. Agents Chemother. (1991) 35:387-389.
25. Quinn P.J., Carter M.E., Markey B.K., Carter G.R., Clinical Veterinary Microbiology, Mosby International, Philadelphia, 1999, pp. 226-236.
26. Reed L.J., Muench H., A simple method of estimating fifty per cent endpoints, Am. J. Hyg. (1937) 27:493-497.
27. Richardson A., Salmonella dublin infection in cattle, Aust. Vet. J. (1974) 50:463-466.
28. Segall T., Lindberg A.A., Oral vaccination of calves with an aromatic-dependent Salmonella dublin (O9, 12) hybrid expressing O4, 12 protects against S. dublin (O9, 12) but not against Salmonella typhimurium (O4, 5, 12), Infect. Immun. (1993) 61:1222-1231. (Pubitemid 23099187)
29. Smith B.P., Reina-Guerra M., Hoiseth S., Stocker B.A., Habasha F., Johnson E., Merritt F.F., Aromatic-dependent Salmonella typhimurium as modified live vaccines for calves, Am. J. Vet. Res. (1984) 45:59-66.
30. Smith B.P., Reina-Guerra M., Stocker B.A., Hoiseth S., Johnson E.H., Vaccination of calves against Salmonella dublin with aromatic-dependent Salmonella typhimurium, Am. J. Vet. Res. (1984) 45:1858-1861.
31. Smith B.P., Salmonellosis, in: Reinhardt R.W. (Ed.), Large animal internal medicine, C.V. Mosby, St. Louis, 1990, pp. 818-822.
32. Smith B.P., Dilling G.W., Roden L.D., Stocker B.A., Vaccination of calves with orally administered aromatic-dependent Salmonella dublin, Am. J. Vet. Res. (1993) 54:1249-1255. (Pubitemid 23281714)
33. Thanassi D.G., Cheng L.W., Nikaido H., Active efflux of bile salts by Escherichia coli, J. Bacteriol. (1997) 179:2512-2518. (Pubitemid 27164547)
34. Tizard I.R., Immunology, Saunders College Publishing, Philadelphia, 1995, pp. 347-358.
35. Uren T., Wijburg O.L.C., Simmons C., Johansen F., Brandtzaeg P., Strugnell R., Vaccine-induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies, Eur. J. Immunol. (2005) 35:180-188. (Pubitemid 40123864)
36. Van Velkinburgh J.C., Gunn J.S., PhoP-PhoQ-regulated loci are required for enhanced bile resistance in Salmonella spp., Infect. Immun. (1999) 67:1614-1622. (Pubitemid 29144373)
37. Watts J.L., Chengappa M.M., Cole J.R., Cooper J.M., Hoffman L.J., Inzana T.J., Owens W.E., Shryock T.R., Thornsberry C., Walker R.D., Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; tentative standard, NCCLS (1997) 17:1-63.
38. World Organization for Animal Health, Manual of diagnostic tests and vaccines for terrestrial animals, OIE, Paris, 2004, pp. 1018-1032.
39. Wray C., McLaren I., Further studies on the use of Gal E mutants of Salmonella ty-phimurium in calves: oral vaccination and toxicity studies, J. Vet. Med. B (1987) 34:22-29.
40. Wray C., Davies R.H., Salmonella infections in cattle, in: Wray C., Wray A. (Eds.), Salmonella in domestic animals, CABI Publishing, New York, 2000, pp. 169-190.
41. Yethon J.A., Gunn J.S., Ernst R.K., Miller S.I., Laroche L., Malo D., Whitfield C., Salmonella enterica serovar Typhimurium waaP mutants show increased susceptibility to polymyxin and loss of virulence in vivo, Infect. Immun. (2000) 68:4485-4491. (Pubitemid 30497714)
42. Yoshida H., Bogaki M., Nakamura M., Nakamura S., Quinolone resistant-determining region in the DNA gyrase gyrA gene of Escherichia coli, Antimicrob. Agents Chemother. (1990) 14:1271-1272. (Pubitemid 20177394)